Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Troriluzole in cerebellar ataxia
NCT03408080Phase 3Active, not recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Dec 2017
- Primary completion
- Dec 2024
- Modality
- Allosteric Modulators, Orthosteric Ligands, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of troriluzole in spinocerebellar ataxia (SCA), multiple system atrophy (MSA), sponsored by University of California, Los Angeles. Started Dec 2017; status: active, not recruiting.
02
Drugs
troriluzole
03
Conditions
spinocerebellar ataxia (SCA)multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT03408080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03408080.